Patients with rheumatic diseases less frequently receive medications to treat OUD, compared with general population estimates ...

Long-term flare risk and remission rates did not differ between patients with well-controlled RA who tapered vs continued MTX therapy.

Health care resource use increased in patients with Sjögren disease during the year after diagnosis, especially among those with comorbid autoimmune disorders.

Baron Health Care Fund gained for the quarter and outperformed its benchmark, the Russell 3000 Health Care Index. Read more ...

A whistling, ringing, buzzing or whooshing - for some it may be roaring or hissing. Tinnitus, the perception of sound with no ...

Swiss pharma giant Roche Holding AG RHHBY reported sales of CHF 14.9 billion for the third quarter of 2025, up 6% year over year at constant exchange rates (CER), driven by the strong demand for its ...

The ancient practice of acupuncture or dry needling works by stimulating nerves beneath the skin and in the muscles and ...

Group sales In the first nine months of 2025, Roche achieved sales growth of 7% (2% in CHF) to CHF 45.9 billion due to strong demand for our pharmaceutical and diagnostic products.

The new biotech Elevara plans to initiate Phase II testing of its lead candidate ELV001 as an add-on treatment for rheumatoid ...

New research presented at ACR 2025 shows GLP-1 receptor agonists, used for diabetes and obesity, may reduce rheumatoid ...

Weight loss drugs known as GLP-1 receptor agonists are sometimes referred to as “miracle drugs,” not only because they help people lose weight, but because they’ve also been shown to help with many ...

In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has ...